Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

QUANTIMETRIX CORP

Quantimetrix Corporation designs, develops, and manufactures ready-to-use liquid laboratory quality control and testi... read more Featured Products: More products

Download Mobile App




Founder of Quantimetrix Dies at 89

By LabMedica International staff writers
Posted on 24 Oct 2016
Dr. More...
Robert William Ban, who founded Quantimetrix Corporation (Redondo Beach, CA, USA) over 40 years ago, and led the company's growth into a powerhouse in laboratory liquid control systems, died peacefully in California at the age of 89.

Dr. Ban, a PhD in Bichemistry, started Quantimetrix in 1974 as a result a number of successful experiments he conducted in his garage. The company pioneered a liquid stabilization technology that simplified quality control methods in the laboratory. With the Clinical Laboratory Improvement Act (CLIA) of 1988 mandating the use of controls in clinical laboratories, Quantimetrix provided the products to a diagnostic community eager to abide by the new requirements. The demand for Quantimetrix products soared and established the company as a global leader in the field.

Earlier in 1972, Dr. Ban also founded Diagnostic Products Corporation (DPC), a developer of radioimmunoassay (RIA) diagnostic test kits. The test, considered a breakthrough at the time, permitted the measurement of infinitesimally low concentrations of substances in bodily fluids, such as drugs and hormones. Dr. Ban left DPC in 1973, and subsequently started Quantimetrix.

Dr. Ban was a storied innovator and a tireless leader who was active around the world. His son, Monty Scott Ban, continues to pursue his vision as the current chairman and CEO of the company.

Besides his active business life, Dr. Ban was also a published author, artist, poet, and musician. He is survived by his son, daughter-in-law, and three granddaughters.

Related Links:
Quantimetrix


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.